hem6: an ENU-induced recessive hypochromic microcytic anemia mutation in the mouse.

Mouse models have proven invaluable for understanding erythropoiesis. Here, we describe an autosomal recessive, inherited anemia in the mouse mutant hem6. Hematologic and transplantation analyses reveal a mild, congenital, hypochromic, microcytic anemia intrinsic to the hematopoietic system that is associated with a decreased red blood cell zinc protoporphyrin to heme ratio, indicative of porphyrin insufficiency. Intercross matings show that hem6 can suppress the porphyric phenotype of mice with erythropoietic protoporphyria (EPP). Furthermore, iron uptake studies in hem6 reticulocytes demonstrate defective incorporation of iron into heme that can be partially corrected by the addition of porphyrin precursors. Gene expression and enzymatic assays indicate that erythroid 5-aminolevulinic acid synthase (Alas2) is decreased in hem6 animals, suggesting a mechanism that could account for the anemia. Overall, these data lead to the hypothesis that hem6 encodes a protein that directly or indirectly regulates the expression of Alas2.

[1]  P. Man,et al.  Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells. , 2007, Experimental hematology.

[2]  Claire M. Brown,et al.  Direct interorganellar transfer of iron from endosome to mitochondrion. , 2006, Blood.

[3]  M. Fleming,et al.  The Steap proteins are metalloreductases. , 2006, Blood.

[4]  P. Ney.  Gene expression during terminal erythroid differentiation , 2006, Current opinion in hematology.

[5]  J. Phillips,et al.  Biosynthesis of heme in mammals. , 2006, Biochimica et biophysica acta.

[6]  A. Brownlie,et al.  Mitoferrin is essential for erythroid iron assimilation , 2006, Nature.

[7]  J. J. Sharp,et al.  nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. , 2005, Blood.

[8]  J. J. Sharp,et al.  Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells , 2005, Nature Genetics.

[9]  B. Paw,et al.  Deficiency of glutaredoxin 5 reveals Fe–S clusters are required for vertebrate haem synthesis , 2005, Nature.

[10]  M. Fleming,et al.  Heme-regulated eIF2α kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and β-thalassemia , 2005 .

[11]  T. Rouault,et al.  Iron–sulphur cluster biogenesis and mitochondrial iron homeostasis , 2005, Nature Reviews Molecular Cell Biology.

[12]  D. Richardson,et al.  Iron trafficking in the mitochondrion: novel pathways revealed by disease. , 2005, Blood.

[13]  M. Fleming,et al.  Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and beta-thalassemia. , 2005, The Journal of clinical investigation.

[14]  S. Klinken,et al.  New Insights into the Regulation of Erythroid Cells , 2004, IUBMB life.

[15]  Bin Liu,et al.  Functional genetic analysis of mouse chromosome 11 , 2003, Nature.

[16]  O. Nakajima,et al.  Articles on similar topics can be found in the following Blood collections Hematopoiesis and Stem Cells (3094 articles) , 2002 .

[17]  M. Fleming.  The genetics of inherited sideroblastic anemias. , 2002, Seminars in hematology.

[18]  N. Andrews.  Animal models of hereditary iron transport disorders. , 2002, Advances in experimental medicine and biology.

[19]  K. Manly,et al.  Map Manager QTX, cross-platform software for genetic mapping , 2001, Mammalian Genome.

[20]  D K Stevenson,et al.  Zinc protoporphyrin: A metabolite with a mission. , 1999, Clinical chemistry.

[21]  O. Nakajima,et al.  Heme deficiency in erythroid lineage causes differentiation arrest and cytoplasmic iron overload , 1999, The EMBO journal.

[22]  T. Sadlon,et al.  Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis. , 1999, The international journal of biochemistry & cell biology.

[23]  Timothy C. Cox,et al.  Identification and Characterization of a Conserved Erythroid-specific Enhancer Located in Intron 8 of the Human 5-Aminolevulinate Synthase 2 Gene* , 1998, The Journal of Biological Chemistry.

[24]  N. Andrews,et al.  Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Cox,et al.  Transcriptional Regulation of the Human Erythroid 5-Aminolevulinate Synthase Gene , 1997, The Journal of Biological Chemistry.

[26]  N. Andrews,et al.  Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene , 1997, Nature genetics.

[27]  Stephan Nussberger,et al.  Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.

[28]  R. Crystal.  Managed care for viruses , 1997, Nature Medicine.

[29]  P. Ponka.  Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. , 1997, Blood.

[30]  T. Cox,et al.  Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia , 1995, Journal of bioenergetics and biomembranes.

[31]  H. Dailey,et al.  Mammalian ferrochelatase. Expression and characterization of normal and two human protoporphyric ferrochelatases. , 1994, The Journal of biological chemistry.

[32]  J. Conboy,et al.  Human erythroid 5-aminolevulinate synthase. Gene structure and species-specific differences in alternative RNA splicing. , 1992, The Journal of biological chemistry.

[33]  J. Guénet,et al.  Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease. , 1991, The Journal of clinical investigation.

[34]  T. Cox,et al.  Human erythroid 5‐aminolevulinate synthase: promoter analysis and identification of an iron‐responsive element in the mRNA. , 1991, The EMBO journal.

[35]  N. Gray,et al.  Identification of a novel iron‐responsive element in murine and human erythroid delta‐aminolevulinic acid synthase mRNA. , 1991, The EMBO journal.

[36]  J. Hoke,et al.  Ferric‐salicylaldehyde isonicotinoyl hydrazone, a synthetic iron chelate, alleviates defective iron utilization by reticulocytes of the belgrade rat , 1991, Journal of cellular physiology.

[37]  X. Montagutelli,et al.  A Recessive Inherited Ferrochelatase Deficiency with Anemia, Photosensitivity, and Liver Disease , 1991 .

[38]  L. Gardner,et al.  Biosynthesis of heme in immature erythroid cells. The regulatory step for heme formation in the human erythron. , 1988, The Journal of biological chemistry.

[39]  G. Stamatoyannopoulos,et al.  The molecular basis of blood diseases , 1987 .

[40]  P. Romeo,et al.  Molecular cloning and nucleotide sequence of a complete human uroporphyrinogen decarboxylase cDNA. , 1986, The Journal of biological chemistry.

[41]  L. Kozak,et al.  Ovarian teratomas in mice are derived from oocytes that have completed the first meiotic division , 1977, Nature.

[42]  S. Granick,et al.  Two methods for determining the activity of delta-aminolevulinate synthetase within intact liver cells in culture. , 1977, Analytical biochemistry.

[43]  G. Cartwright,et al.  Sideroblasts, siderocytes, and sideroblastic anemia. , 1975, The New England journal of medicine.